Cargando…
Metformin Decreases 2-HG Production through the MYC-PHGDH Pathway in Suppressing Breast Cancer Cell Proliferation
The biguanide drug metformin has been widely used for the treatment of type 2 diabetes, and there is evidence supporting the anticancer effect of metformin despite some controversy. Here, we report the growth inhibitory activity of metformin in the breast cancer (MCF-7) cells, both in vitro and in v...
Autores principales: | Oh, Sehyun, Cho, Youngup, Chang, Minsun, Park, Sunghyouk, Kwon, Hyuknam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402004/ https://www.ncbi.nlm.nih.gov/pubmed/34436421 http://dx.doi.org/10.3390/metabo11080480 |
Ejemplares similares
-
PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma
por: D’Avola, Annalisa, et al.
Publicado: (2022) -
Elevated Nuclear PHGDH Synergistically Functions with cMyc to Reshape the Immune Microenvironment of Liver Cancer
por: Zhu, Hongwen, et al.
Publicado: (2023) -
Validating and enabling phosphoglycerate dehydrogenase (PHGDH) as a target for fragment-based drug discovery in PHGDH-amplified breast cancer
por: Unterlass, Judith E., et al.
Publicado: (2016) -
Simultaneous suppression of PKM2 and PHGDH elicits synergistic anti-cancer effect in NSCLC
por: Wang, Kaixuan, et al.
Publicado: (2023) -
Down regulating PHGDH affects the lactate production of sertoli cells in varicocele
por: Guo, Wen-bin, et al.
Publicado: (2020)